入院HbA1c高于6%与院外心脏骤停后6个月生存率降低及不良结局相关:一项回顾性队列研究
该单中心回顾性队列研究纳入2011年12月至2019年12月期间接受低温目标温度管理的成人院外心脏骤停幸存者302例,其中102例(33.8%)入院HbA1c>6%。高HbA1c组6个月生存率显著低于非高HbA1c组(12.7% vs 37.5%,p<0.001),6个月不良神经结局(大脑功能分级3-5分)比例显著更高(89.2% vs 73.0%,p=0.001)。多变量logistic回归显示HbA1c>6%与6个月死亡率(OR 5.85,95%CI 2.26-15.12)及不良结局(OR 4.18,95%CI 1.41-12.40)独立相关。提示长期血糖管理不佳可能对心脏骤停后预后具有预测意义。
要点
- 在302例接受低温目标温度管理的成人院外心脏骤停幸存者中,33.8%入院HbA1c>6%。
- 高HbA1c组6个月生存率12.7%,非高HbA1c组37.5%(p<0.001)。
- 高HbA1c组6个月不良神经结局(CPC 3-5分)比例89.2%,非高HbA1c组73.0%(p=0.001)。
- 多变量分析中HbA1c>6%与6个月死亡率独立相关(OR 5.85,95%CI 2.26-15.12)。
- HbA1c>6%与6个月不良神经结局独立相关(OR 4.18,95%CI 1.41-12.40)。
适用人群与场景
- 成人院外心脏骤停幸存者,接受低温目标温度管理,收治于单中心。
诊断标准与关键阈值
- 入院HbA1c>6%定义为高HbA1c。
- 不良神经结局定义为大脑功能分级(CPC)评分3-5分。
研究设计与关键结果
- 研究类型为单中心回顾性队列研究,纳入2011年12月至2019年12月接受低温目标温度管理的成人院外心脏骤停幸存者,最终分析302例;高HbA1c组102例(33.8%)。
- 主要终点6个月死亡率:高HbA1c组12.7% vs 非高HbA1c组37.5%(p<0.001),高HbA1c组生存率更低。
- 次要终点6个月不良神经结局(CPC 3-5分):高HbA1c组89.2% vs 非高HbA1c组73.0%(p=0.001)。
- Kaplan-Meier分析和log-rank检验显示高HbA1c组生存时间显著短于非高HbA1c组。
- 多变量logistic回归:HbA1c>6%与6个月死亡率独立相关(OR 5.85,95%CI 2.26-15.12,p<0.001),与不良神经结局独立相关(OR 4.18,95%CI 1.41-12.40,p<0.001)。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为长期血糖管理不佳可能对心脏骤停后预后具有预测意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: To evaluate the associations between glycated hemoglobin (HbA1c) at admission and 6-month mortality and outcomes after out-of-hospital cardiac arrest (OHCA) treated by hypothermic targeted temperature management (TTM).
METHODS: This single-center retrospective cohort study included adult OHCA survivors who underwent hypothermic TTM from December 2011 to December 2019. High HbA1c at admission was defined as a level higher than 6%. Poor neurological outcomes were defined as cerebral performance category scores of 3-5. The primary outcome was 6-month mortality. The secondary outcome was the 6-month neurological outcome. Descriptive statistics, log-rank tests, and multivariable regression modeling were used for data analysis.
RESULTS: Of the 302 patients included in the final analysis, 102 patients (33.8%) had HbA1c levels higher than 6%. The high HbA1c group had significantly worse 6-month survival (12.7% vs. 37.5%, p < 0.001) and 6-month outcomes (89.2% vs. 73.0%, p = 0.001) than the non-high HbA1c group. Kaplan-Meier analysis and the log-rank test showed that the survival time was significantly shorter in the patients with HbA1c > 6% than in those with HbA1c ≤6%. In the multivariable logistic regression analysis, HbA1c > 6% was independently associated with 6-month mortality (OR 5.85, 95% CI 2.26-15.12, p < 0.001) and poor outcomes (OR 4.18, 95% CI 1.41-12.40, p < 0.001).
CONCLUSIONS: This study showed that HbA1c higher than 6% at admission was associated with increased 6-month mortality and poor outcomes in OHCA survivors treated with hypothermic TTM. Poor long-term glycemic management may have prognostic significance after cardiac arrest.
参考来源
- Lee J, Oh JS, Zhu JH, et al. High HbA1c is associated with decreased 6-month survival and poor outcomes after out-of-hospital cardiac arrest: a retrospective cohort study. Scand J Trauma Resusc Emerg Med. 2020. PMID: 32883318. doi:10.1186/s13049-020-00782-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。